
Sponsored by Monica De La Cruz (R)
Preventing the Financing of Illegal Synthetic Drugs Act
Orders a federal study of how money moves in synthetic drug trafficking.
Tradeoff
Requires a federal watchdog study of how criminal groups finance synthetic drug sales. Asks for a report to Congress within one year of enactment.
What's in it
The House passed this bill 402-2 on May 22, 2023. The Senate passed it by on July 23, 2024, and it became law in September 2024.
House
Introduced
(Feb 17, 2023)
House
Committee on Financial Services(Feb 17, 2023)
The bill went to more than one committee at the same time.
House
The Committee on Financial Services voted to send it to the floor
Reported by (Feb 28, 2023)
Committee report H. Rept. 118-75, Part I.
House
On Motion to and Pass, as Amended
Passed(Roll #228 · May 22, 2023)
402 yeanay 2Senate
Received from the House
on Banking, Housing, and Urban Affairs(May 30, 2023)
Senate
Passage of the bill
Passed by (Jul 23, 2024)
No individual votes were recorded.
Senate
Taken away from the Committee on Banking, Housing, and Urban Affairs
Discharged(Jul 23, 2024)
House
Sent to the President
(Sep 11, 2024)

White House · Signature
Signed
Joe Biden (D)

Enacted
Became law(Sep 13, 2024)
- Brittany Pettersen (D-CO)
- Andrew Ogles (R-TN)
- Michael Lawler (R-NY)
- Lori Chavez-DeRemer (R-OR)
- Byron Donalds (R-FL)
- Bryan Steil (R-WI)
- Chris Pappas (D-NH)
- Marie Gluesenkamp Perez (D-WA)
Final passage· May 22, 2023· 118th Congress · 2023–2025